Information was received from a healthcare professional (hcp) via manufacturer representative regarding a patient who was receiving morphine, concentration 10mg/ml at a dose/frequency of 2.6 mg/day via intrathecal drug delivery pump for non-malignant pain and other chronic/intractable pain (trunk/limbs).It was reported that the patient had a medical condition.It was reported that the patient had a viral infection and was in the intensive care unit and was medically sedated which had been stopped at the time of this report, and was still experiencing sedation and was lethargic.It was reported that the patient had respiratory failure as well at some point.It was reported that the hcp did not think the patient's symptoms were related to the pump; however they wanted to decrease the dose to see if her symptoms improved.The hcp reported that he reduced the dose by 50%.It was reported that the hcp asked about intrathecal to oral administration conversion for morphine, and the technical service specialist (tss) reviewed the information they had goes the other way and they could not use the same conversion; the tss suggested the hcp contact a pharmaceutical company and provided contact information.There were no interventions reported.It was reported that this was considered a sudden change in therapy/symptoms.It was reported that the hcp did not think the symptoms were device related at the time of this report.It was reported that the patient was hospitalized at the time of this report.No further complications were reported.
|